Translational Molecular Discoveries (TMD), an FIU Emerging Preeminent Program, will integrate the basic and applied research efforts of faculty members across disciplines for the benefit of human health and wellness.
The TMD program will include focus areas on:
- Drug discovery to meet urgent needs for new therapies against cancer, drug-resistant infection and neurodegenerative diseases;
- Predictive biomarkers for personalized medicine & wellness; and
- Control of mosquito-borne diseases by novel molecular approaches.
Many TMD faculty are internationally recognized leaders in their fields. They serve as journal editors or on editorial boards and are invited to serve on NIH, NSF and DOD grant review panels in recognition of their scientific achievements and expertise. Collaborations with NIH scientists and clinicians are part of the translational research and drug discovery focus of TMD.
Training New Scientists
Ph.D. students and postdoctoral fellows are receiving research training from TMD faculty members, learning to use state-of-the-art mass spectrometry, animal models, bioinformatics and computational biology. Recent Ph.D. graduates have job placements in diverse career paths, including government, industry and academic positions. TMD faculty have coauthored more than 180 publications with students.
Engaging the Community
Our interdisciplinary researchers are working toward solutions to critical health challenges facing South Floridians and people around the world.
Faculty in the Translational Molecular Discoveries program include current Biomolecular Sciences Institute (BSI) members from the College of Arts, Sciences and Education (CASE); the Herbert Wertheim College of Medicine (HWCOM); the Robert Stempel College of Public Health & Social Work (RSCPHSW); and the College of Engineering & Computing (CEC). In addition, the program partners with FIU's Advanced Mass Spectrometry Facility (AMSF), the International Center for Tropical Botany (ICTB) and the Nicole Wertheim College of Nursing & Health Sciences (NWCNHS).
Monday, September 09, 2019
Dr. Francisco Fernandez-Lima and postdoctoral fellow Kevin Jeanne Dit Fouque were recently awarded a U.S. patent for their invention: “Materials […]
Tuesday, June 04, 2019
FIU is launching a transdisciplinary biomolecular and biomedical sciences training program for doctoral students thanks to a $1.5 million grant from the National Institutes of Health.
Wednesday, April 10, 2019
A biophysics team led by Prem Chapagain and Bernard Gerstman has joined forces with Oragenics Inc. in an effort that could lead to the development of new compounds to treat life-threatening infections.